3Huo W, Di ZH, Xiao BH, et al. Clearance of genital warts in preg- nmt women by mild local hyperthermia: a pilot report. Dermatol T- her, 2014,27(2) :109 - 112.
4Burger EA, Sy S, Nygrd M, et al. Prevention of HPV - related cancers in Norway: cost -effectiveness of expanding the HPV vacci- nation program to include pro -adolescent boys. PLoS One, 2014,9 (3) : e89974.
5Park SJ ,Seo J, Ha SH, et al. Prevalence and determinants of high - risk human papillomavirus infection in male genital warts. Korean J Urol, 2014,55(3) :207 -212.
6Gross G,Rogozinski T,Schfer H,et al.Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts:results of a placebo-controlled double-blind study in 120 patients.Dermatology,1998,196(3):330-334.
7Malek-Sabet N,Masoumian MR,Zeinali M,et al.Production,purification,and chemical stability of recombinant human interferon-γin low oxygen tension condition:a formulation approach.Prep Biochem Biotechnol,2013,43(6):586-600.
8Rachmawati H,Merika A,Ningrum RA,et al.Evaluation of adverse effects of mutein forms of recombinant human interferon alpha-2b in female Swiss webster mice.Biomed Res Int,2013:943687.
9L. Thornsberry,J.C. English.Evidence-Based Treatment and Prevention of External Genital Warts in Female Pediatric and Adolescent Patients[J].Journal of Pediatric and Adolescent Gynecology.2012(2)
10PurnimaBhat,Stephen R.Mattarollo,ChristinaGosmann,Ian H.Frazer,Graham R.Leggatt.Regulation of immune responses to HPVinfection and during HPV‐directed immunotherapy[J].Immunological Reviews.2010(1)
